BAAM
IDYA icon

Baker Avenue Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Baker Avenue Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-54
Closed -$1.46K – 882
2023
Q3 		$1.46K Hold
54
– – ﹤0.01% 1195
2023
Q2 		$1.27K Hold
54
– – ﹤0.01% 1103
2023
Q1 		$741 Hold
54
– – ﹤0.01% 1286
2022
Q4 		$981 Buy
+54
New +$909 ﹤0.01% 1110

Other funds holding IDYA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Baker Avenue Asset Management's IDYA Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of IDEAYA Biosciences (IDYA) in Q4 2023, closing a stake of 54 shares — an estimated $1.46K sold.

Baker Avenue Asset Management first reported a position in IDYA in Q4 2022 and held it in 4 quarters. The position peaked at $1.46K in Q3 2023. 157 funds tracked by Wall St. Rank hold IDYA as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining IDEAYA Biosciences position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 54 IDEAYA Biosciences shares in Q4 2023, an estimated $1.46K.
  • Baker Avenue Asset Management first reported a position in IDEAYA Biosciences in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's IDEAYA Biosciences position peaked at $1.46K in Q3 2023.
  • 157 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.